Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
News Release
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
Workers' Comp
News Release
Enlyte Publishes 2022 Workers’ Compensation Technology Trends Report
SAN DIEGO—Enlyte, the parent brand of Mitchell, Genex and Coventry, today released survey results of its
Workers' Comp
Article
High Dollar Claims Driving Workers’ Compensation COVID-19 Claims Costs
Data analysis by Aarthi Thiruvengadam.
Mitchell
News Release
Symbicort Generic Approval on March 15, 2022
Recently the U.S.
Workers' Comp
Article
High Dollar Claims Driving Workers’ Compensation COVID-19 Claims Costs
Data analysis by Aarthi Thiruvengadam.
Disability
Article
Ticket to Work
We all have bad days at work when we dream about how nice it would be to not have to earn a paycheck. But how long would we be happy?